Submit an Article
Navigate
Home
Editorial Board
Editorial Policies
Current Volume
Archive
Scientific Integrity
Publication Ethics Statements
Interviews with Outstanding Authors
Newsroom
Sponsored Conferences
Podcast
Contact
Special Collections
Submit an Article
Online ISSN: 1945-4589
Research Paper
|
Volume 13, Issue 5
|
pp. 7147–7165
No difference in hepatocellular carcinoma risk in chronic hepatitis B patients treated with tenofovir vs entecavir: evidence from an updated meta-analysis
Back to article
Figure 1
(1 of 3)
−
100%
+
Figure 1.
The flowchart of identifying relevant studies.
HIV, human immunodeficiency virus; HCV, hepatitis C virus; HCC, hepatocellular carcinoma.
